Shelli Kesler, PhD
Academic Appointments
- Assistant Professor (Research), Psychiatry & Behavioral Science - Center for Interdisciplinary Brain Sciences Research
- Member, Bio-X
- Member, Stanford Cancer Institute
Key Documents
Contact Information
-
Clinical Offices
401 Quarry Road Stanford, CA 94305 Tel Work (650) 498-9111 Fax (650) 472-8937Practices at Stanford Hospital and Clinics and Lucile Packard Children's Hospital
- Academic Offices
Alternate Contact Appointment Tel Work 650-498-9111Not for medical emergencies or patient use
Professional Overview
Clinical Focus
- Psychology
- Psychiatry
Honors and Awards
- K07 Career Development Award, NCI (2009)
- Director's Innovator Award, NIH (2008)
Professional Education
| Medical Education: | Brigham Young University UT (2003) |
| Residency: | Adolescent Residential Treatment & Evaluation Center UT (2001) |
| Internship: | University of Utah Medical Center UT (2000) |
| PhD: | BYU, Clinical Neuropsychology (2000) |
Graduate & Fellowship Program Affiliations
Internet Links
Scientific Focus
Current Research Interests
Assessment and treatment of cognitive deficits related to medical problems, particularly cancer. Multi-level research involving neuropsychology, neuroimaging and genetics. Measurement and enhancement of neuroplasticity mechanisms through targeted interventions.
Publications
- Anomalous Gray Matter Structural Networks in Major Depressive Disorder. Biol Psychiatry. 2013
- Cognitive Training for Improving Executive Function in Chemotherapy-Treated Breast Cancer Survivors. Clin Breast Cancer. 2013
- Comparing connectivity pattern and small-world organization between structural correlation and resting-state networks in healthy adults. Neuroimage. 2013: 402-414
- Elevated prefrontal myo-inositol and choline following breast cancer chemotherapy. Brain Imaging Behav. 2013
- Psychosocial predictors of treatment response to cognitive-behavior therapy for late-life depression: an exploratory study. Aging Ment Health. 2013
- Reduced hippocampal volume and verbal memory performance associated with interleukin-6 and tumor necrosis factor-alpha levels in chemotherapy-treated breast cancer survivors. Brain Behav Immun. 2013: S109-16
Help